Supplement Article
Antiretrovirals to Prevent HIV Infection • CID 2015:60 (Suppl 3) • S159 - S160
Twenty-Fourth Annual Trachoma Control Program Review, Summary Proceedings
Over the past weeks, there has been wide media attention on the risk of transmission of the novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] by asymptomatic individuals. This situation has also been extensively discussed on various platforms globally. The purpose of t...his position statement is for the Africa Centres for Diseases Control and Prevention (Africa CDC) to clarify the situation of transmission of SARS-CoV-2 by pre-asymptomatic and asymptomatic Individuals.
more
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
India AIDS Response Report 2014
Journal of Microbiology and Infectious Diseases / 2015; 5 (3): 110-113
JMID, doi: 10.5799/ahinjs.02.2015.03.0187
Please read online the lastest updated versions http://www.cdc.gov/vhf/ebola/qa.html
In this COVID-19 pandemic, timely access to accurate information can be the difference between life and death. The stakes are high in developing countries like Ethiopia where millions of people have limited access to information because of low media access, insufficientin...ternet penetration, illiteracy, and language diversity.
more
Checklist for risk and impact management of pandemics of COVID-19
Maphunziro Othandiza Kusankha Mwanzeru Polimbana ndi Mliri wa Edzi. Bukhu Lophunzitsira Kudzilet sa ku Edzi M’malawi
To generate and manage resources towards this goal, the UN Secretary-General in collaboration with UN Agencies, Funds and Programmes (UN AFP) has launched the UN Zika Response Multi-Partner Trust Fund (Zika Response MPTF). The aim of this inter-agency pooled funding mechanism is to rapidly resource ...the UN system responses to Zika virus, in accordance with the overview of needs and requirements and the Zika Response Framework.
more
Patienteninformation - Englisch
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...tion strategies and case management. More and more immunodiagnostics, mostly rapid diagnostic tests, are being made available as an alternative to NAATs. This type of test can be used out-of-laboratory conditions at large scale.
more